From: Stereotactic radiotherapy is a useful treatment option for patients with medullary thyroid cancer
Patient | sex | age | pT | pN | M | target | Treatment method | Treatment date | Fractionated Dose [Gy] | Total dose [Gy] | Follow-up [years] |
---|---|---|---|---|---|---|---|---|---|---|---|
1. | m | 56 | 2 | 1 | LN, bones, lungs | Th1 Th10 | CK CK | 2012, 2018 | 10 6 | 10 18 | 7 1 |
2. | f | 44 | x | 1 | bones | Th7 L4 | CK CK | 2016 2016 | 10 10 | 30 30 | 3 3 |
3. | f | 65 | x | 1 | bones | Th8 | ST | 10 | 10 | 8 | |
4. | f | 75 | x | 1 | LN, bones liver | Liver | ST-G | 2019 | 12 | 12 | 1 |
5. | f | 39 | 2 | 0 | bones, liver | L4 Th2 | CK CK | 2012 2011 | 8 8 | 16 16 | 8 9 |
6. | f | 60 | 3 | 1 | bones, liver | Skull Liver | CK CK | 2012 2012 | 10 8 | 10 8 | 1 1 |
7. | f | 65 | x | 1 | LN, liver | LN | CK | 2018 | 8 | 24 | 1 |
8. | m | 44 | 4 | 1 | bones | Th6 L1 | CK CK | 2013 2013 | 7 10 | 21 20 | 1 1 |
9. | f | 62 | 4 | 1 | Lungs, local recurrence | Recurrence | St | 2006 | 8 | 8 | 2 |
10. | m | 24 | 1 | 0 | 0 | Primary thyroid tumor | St | 2017 | 12 | 36 | 1 |
11. | m | 50 | 3 | 1 | Retropharyngeal LN | LN | CK | 2016 | 5 | 45 | 3 |